Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Acaria, accredited, Accredo, accreted, adding, aforementioned, arriving, ASAM, Avella, batch, battle, belief, borrow, borrowing, box, burn, campaign, cap, capped, caregiver, Caremark, carryforward, channel, Cloud, combatting, comfort, consecutive, conserve, consortium, Cosmetic, couple, curb, CVS, deep, delist, delisting, depth, disposal, dollar, domestic, Dow, DUSTR, economy, evolution, geographic, globe, HCP, history, hosting, implicit, inactivation, incremental, invoice, largest, Leaseexpense, lieu, magnitude, matter, modest, nalmefene, Nonemployee, nonpermitted, obsolescence, odd, online, outbreak, outdated, pandemic, paramount, portal, preemptive, prompt, ProNet, provincial, QT, rapid, readily, reassuring, redundant, Refining, reinforcement, relatedrevenue, remeasure, repaid, robust, Rolling, sentiment, shipping, Simplification, situation, Sixmo, software, Southside, spirit, spread, subgroup, subscribe, teleconference, theprivate, therisk, unpaid, Veteran, waiting, weapon, workforce, write, Wuhan
Removed:
Abbvie, adult, advanced, Apokyn, assessed, aware, Birmingham, Boehringer, brain, called, Cambridge, carbidopa, CDS, chapter, cleared, composite, consult, conveniently, conventional, core, decade, delinquent, depreciation, diploma, diversity, dopaminergic, double, Dundee, duodenum, Duodopa, Employer, ER, Ethology, expended, filer, focusing, function, graph, Hyderabad, immobility, impairment, incorporate, infusion, Ingelheim, interactive, interested, interlocking, Ireland, lesioned, levodopa, London, mark, MBChB, MeRaD, metabolic, Mirapex, MKT, motor, movement, MPTP, Neupro, neuroscience, Nox, NYSE, onset, optimization, palliate, paper, Parkinsonian, Parlodel, partnership, PD, permanent, poor, potency, preceding, primate, principle, proxy, Psychological, pulsatile, Rajinder, Ranbaxy, recovering, Reddy, redeemable, reflecting, region, reinvested, Requip, Royal, safely, seasoned, segregated, shell, soliciting, stimulation, subdermal, summarized, symptom, Synaptic, telephone, threatened, tolerance, treated, triiodothyronine, UCB, underwriter, urged, Washington, XL, Yesx
Filing tables
Filing exhibits
Associated TTNP transcripts
TTNP similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (File Nos. 333-226841 and 333-233722), Form S-8 (File Nos. 333-171181 and 333-207950) and Form S-3 (File Nos. 333-230742 and 333-221126) of our report dated March 30, 2020 (which report expresses an unqualified opinion and includes an explanatory paragraph expressing substantial doubt about the Company’s ability to continue as a going concern) relating to the financial statements of Titan Pharmaceuticals, Inc., which appears in this Annual Report on Form 10-K.
/s/ OUM & CO. LLP
San Francisco, California
March 30, 2020